|
166
|
622
|
9n3yL |
Type iv-a1 crispr effector complex bound to dsdna and casding - loaded state |
|
27
|
82
|
9rzkB |
Rapta-6mb (ruthenium[ii]-hexamethylbenzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
35
|
94
|
9loxD |
Cryo-em structure of the chromatin remodeler rad26 bound to the nucleosome at shl6 |
|
24
|
79
|
9loxB |
Cryo-em structure of the chromatin remodeler rad26 bound to the nucleosome at shl6 |
|
31
|
97
|
9rznA |
Rapta-3ib (ruthenium[ii]-1,3,5-triisopropylbenzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
169
|
574
|
9loxK |
Cryo-em structure of the chromatin remodeler rad26 bound to the nucleosome at shl6 |
|
29
|
95
|
9loxC |
Cryo-em structure of the chromatin remodeler rad26 bound to the nucleosome at shl6 |
|
27
|
82
|
9rznB |
Rapta-3ib (ruthenium[ii]-1,3,5-triisopropylbenzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
31
|
106
|
9rzkC |
Rapta-6mb (ruthenium[ii]-hexamethylbenzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
37
|
95
|
9rzkD |
Rapta-6mb (ruthenium[ii]-hexamethylbenzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
30
|
101
|
9loxA |
Cryo-em structure of the chromatin remodeler rad26 bound to the nucleosome at shl6 |
|
31
|
97
|
9rzkA |
Rapta-6mb (ruthenium[ii]-hexamethylbenzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
36
|
95
|
9rznD |
Rapta-3ib (ruthenium[ii]-1,3,5-triisopropylbenzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
32
|
106
|
9rznC |
Rapta-3ib (ruthenium[ii]-1,3,5-triisopropylbenzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
11
|
76
|
9srxE |
Cryo-em structure of the mlc repressor in complex with the glucose-specific iicb transporter |
|
24
|
83
|
10glB |
Nucleosome containing an 8oxog:a at shl+3 |
|
27
|
109
|
10gmC |
Nucleosome containing an 8oxog:a at shl+2 |
|
26
|
109
|
10goC |
Nucleosome containing an 8oxog at shl+2 |
|
33
|
94
|
10gmD |
Nucleosome containing an 8oxog:a at shl+2 |
|
29
|
108
|
10gjC |
Nucleosome containing an 8oxog:a at shl-6 |
|
29
|
98
|
10glA |
Nucleosome containing an 8oxog:a at shl+3 |
|
26
|
96
|
10gmA |
Nucleosome containing an 8oxog:a at shl+2 |
|
34
|
95
|
9ry3D |
Rapta-b (ruthenium[ii]-benzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
32
|
106
|
9rxvC |
Rapta-t (ruthenium[ii]-toluene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
27
|
82
|
9rxuB |
Rapta-c (ruthenium[ii]-cymene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
30
|
93
|
10gnD |
Nucleosome containing an 8oxog at shl+3 |
|
32
|
93
|
10gjD |
Nucleosome containing an 8oxog:a at shl-6 |
|
27
|
98
|
10gkA |
Nucleosome containing an 8oxog:a at shl+4 |
|
38
|
95
|
9rxuD |
Rapta-c (ruthenium[ii]-cymene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
30
|
97
|
9ry3A |
Rapta-b (ruthenium[ii]-benzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
21
|
81
|
10gnB |
Nucleosome containing an 8oxog at shl+3 |
|
27
|
96
|
10goA |
Nucleosome containing an 8oxog at shl+2 |
|
27
|
81
|
10gkB |
Nucleosome containing an 8oxog:a at shl+4 |
|
23
|
80
|
10gjB |
Nucleosome containing an 8oxog:a at shl-6 |
|
26
|
96
|
10gjA |
Nucleosome containing an 8oxog:a at shl-6 |
|
32
|
106
|
9ryaC |
Rapta-3mb (ruthenium[ii]-1,3,5-trimethylbenzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
31
|
93
|
10gkD |
Nucleosome containing an 8oxog:a at shl+4 |
|
32
|
106
|
9ry3C |
Rapta-b (ruthenium[ii]-benzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
105
|
398
|
9srwA |
Cryo-em structure of the mlc tetramer in complex with the anti-repressor mtfa |
|
104
|
395
|
9srtA |
Cryo-em structure of the mlc tetramer |
|
26
|
97
|
10gnA |
Nucleosome containing an 8oxog at shl+3 |
|
24
|
81
|
10gmB |
Nucleosome containing an 8oxog:a at shl+2 |
|
112
|
399
|
9sruA |
Cryo-em structure of mlc in complex with ptsg operator dna |
|
31
|
94
|
10glD |
Nucleosome containing an 8oxog:a at shl+3 |
|
35
|
95
|
9ryaD |
Rapta-3mb (ruthenium[ii]-1,3,5-trimethylbenzene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
219
|
667
|
26czA |
Cryo-em structure of the hexameric drt3b complex |
|
34
|
106
|
9rxuC |
Rapta-c (ruthenium[ii]-cymene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
35
|
95
|
9rxvD |
Rapta-t (ruthenium[ii]-toluene-phosphaadamantane) cancer drug binding to the nucleosome core |
|
24
|
82
|
10goB |
Nucleosome containing an 8oxog at shl+2 |
|
29
|
109
|
10glC |
Nucleosome containing an 8oxog:a at shl+3 |
